Description
Mounjaro is a prescription weight loss treatment manufactured by Eli Lilly.What is Mounjaro?Mounjaro is a weight loss treatment intended for individuals with a body mass index (BMI) over 30. It is an injection pen that contains the medication tirzepatide. The Mounjaro pen is a registered trademark of Eli Lilly.It may also be suitable for individuals with a BMI over 27 who have been diagnosed with weight-related medical conditions, including:Type 2 diabetesHigh cholesterolObstructive sleep apneaHigh blood pressureHow does it work?Mounjaro contains tirzepatide, an active ingredient belonging to a class of drugs called GLP-1 agonists. GLP-1 agonists regulate hunger and are released by the intestines after a meal.By functioning similarly to GLP-1, Mounjaro helps control appetite, leading to a feeling of fullness and reduced